For immediate release – Oxford, UK – May 12th, 2025 – Kudos, the platform for showcasing research, has today announced a new collaboration with Oxford PharmaGenesis, a global leader in HealthScience communications. The partnership will help pharmaceutical, biotech, and healthcare research organizations take a more strategic approach to omnichannel communications by combining expertise in medical content and strategy from Oxford PharmaGenesis with the Kudos platform and audience.
Clients will benefit from more rapid delivery of microsites that bring evidence-led storytelling – through plain language summaries, clinical trial data, infographics, videos, prescribing information and more – to target audiences such as healthcare practitioners, researchers and patients. Kudos also includes sophisticated tools for planning, managing and measuring omnichannel communications. The Oxford PharmaGenesis ‘serviced edition’ of Kudos provides companies with an end-to-end package for creating, disseminating, and measuring the impact of medical content.
“Pharma and med affairs teams often face a fragmented communications landscape, where great content is created but struggles to reach the right audiences,” said Charlie Rapple, co-founder of Kudos. “This partnership solves that – bringing together strategy, execution, and a powerful platform to engage and inform with precision.”
“We’re excited to partner with Kudos to offer our current and prospective clients a new level of control and clarity over their communications,” said Chris Winchester, CEO of Oxford PharmaGenesis. “This is about helping our clients deliver measurable value – not just by reaching audiences, but by taking them on structured, evidence-based learning journeys.”
The partnership is built around a flexible package model, combining Kudos’ platform with Oxford PharmaGenesis’ services – from strategic communications planning through to content development and deployment. Use cases range from biotech firms communicating about a single product, to large pharmaceutical companies organizing and optimizing high volumes of medical content.
The collaboration will also unlock deeper audience insights. Kudos’ analytics, combined with Oxford PharmaGenesis qualitative research and proprietary tools, will enable clients to understand not just what content is being consumed – but how it influences perception, behavior, and medical decision-making.
For more information or to request a demonstration, please contact tomas.rees@pharmagenesis.com or charlie@growkudos.com.
— ENDS —
Contact:
Charlie Rapple
charlie@growkudos.com
About Kudos
Kudos (growkudos.com) is the platform for showcasing research, helping more people find, understand and use it. Over 560,000 researchers use Kudos to bring science to life through the power of storytelling. Kudos is the only toolkit designed specifically to drive research communications, engagement and impact, helping researchers cross boundaries, achieve more influence, and gain more recognition.
About Oxford PharmaGenesis
Oxford PharmaGenesis is an independent, award-winning HealthScience communications consultancy with 500 employees in North America, Europe and Asia Pacific. Established in 1998, the company specialises in providing strategic consultancy across various domains, including medical communications, medical affairs, market access and value demonstration, health economics and outcomes research (HEOR), publications, and patient engagement. With a commitment to quality and innovation, Oxford PharmaGenesis partners with clients to accelerate the adoption of evidence-based innovations for patients in areas of unmet medical need.